SEC FORM 5

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0362
Estimated average burden
hours per response:			1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

Keinan Ehud

(Last)

(First)

(Middle)

8 MORAN STREET

(Street)

TIMRAT

10505

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ACRO INC. [ ACRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2007

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/22/2006		P4	2,000	A	$1.75	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	12/26/2006		P4	900	A	$1.55	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	01/22/2007		P4	2,500	A	$1.4	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	01/23/2007		P4	4,500	A	$1.35	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	01/26/2007		P4	9,000	A	$1.3	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	02/23/2007		S4	19,000	A	$1.45	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	02/28/2007		P4	10,000	A	$1.08	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	03/01/2007		P4	10,000	A	$1.12	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	03/20/2007		P4	500	A	$1.06	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	03/20/2007		P4	4,150	A	$1.02	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	03/20/2007		P4	1,600	A	$1.04	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	03/21/2007		P4	3,750	A	$1.06	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	04/09/2007		P4	425	A	$0.83	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	04/12/2007		P4	8,000	A	$0.83	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	04/25/2007		P4	11,000	A	$0.56	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	05/07/2007		P4	5,000	A	$0.39	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	05/07/2007		P4	3,000	A	$0.4	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	07/26/2007		P4	4,400	A	$0.42	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	07/27/2007		P4	5,000	A	$0.42	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	07/30/2007		P4	5,000	A	$0.36	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	07/31/2007		P4	35,000	A	$0.31	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	08/21/2007		P4	20,000	A	$0.27	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	09/25/2007		P4	2,110	A	$0.13	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	11/01/2007		P4	12,800	A	$0.12	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	11/02/2007		P4	1,500	A	$0.12	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	11/23/2007		P4	30,000	A	$0.1	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	12/10/2007		P4	300	A	$0.08	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	12/12/2007		P4	23,250	A	$0.07	20,902,494	I⁽¹⁾	See Footnote⁽²⁾
Common Stock	12/14/2007		P4	2,240	A	$0.07	20,902,494	I⁽¹⁾	See Footnote⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. 502,497 shares of Common Stock out of the 20,902,494 shares are held directly by Mr. Keinan.

2. The shares are registered under BioTech Knowledge, which is a company wholly owned by Ehud Keinan. (BioTech Knowledge LLC 10550 North Torrey Pines Road, Mb-20 La Jolla, CA, 92037)

	/s/ Ehud Keinan	01/27/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.